regulatory-affairs-head

Medical device submission strategy for FDA and EU MDR requires creating integrated regulatory plans covering product specifics, target markets, and timelines. You can generate coordinated pathways, dossiers, and strategy documents to streamline multi-market compliance and market access.

FDA medical device submission pathways include 510(k), PMA, and De Novo. You can evaluate your device characteristics against these options to generate a tailored regulatory strategy, compiling necessary submission artifacts and planning appropriate clinical evidence requirements.

Global market access for medical devices can be coordinated across FDA, EU MDR, Health Canada, PMDA, and NMPA. You can develop multi-market registration strategies that align regulatory requirements, timelines, and documentation to streamline international compliance.

EU MDR documentation and risk assessments for medical devices are prepared by compiling regulatory dossiers, checklists, and risk management files. You can generate compliant artifacts and clinical evidence planning tailored to EU MDR requirements.

Regulatory strategy for medical devices supports post-market considerations by integrating them into the end-to-end submission plan. You can generate pathway documents that include post-market surveillance requirements alongside pre-market submission artifacts and timelines.